3-(2-氟-4-甲氧基苯基)丙烯酸甲酯 | 852181-14-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 中文名称: 3-(2-氟-4-甲氧基苯基)丙烯酸甲酯
• 英文名称: 3-(2-fluoro-4-methoxyphenyl)acrylic acid methyl ester
• 英文别名: 2-fluoro-4-methoxycinnamic acid methyl ester；(E)-Methyl 3-(2-fluoro-4-methoxyphenyl)acrylate；methyl (E)-3-(2-fluoro-4-methoxyphenyl)prop-2-enoate
• CAS: 852181-14-7
• 化学式: C₁₁H₁₁FO₃
• 分子量: 210.205
• InChiKey: YUIHJWVNGQTMNF-GQCTYLIASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2-氟-4-甲氧基苯基)丙烯酸甲酯 在 palladium on activated charcoal sodium hydroxide 、 氢气 作用下， 以 甲醇 为溶剂， 反应 23.0h， 生成 2-氟-4-甲氧基-苯丙酸
  参考文献：
  名称：

  手性构件：苄氧基甲基苯基丙酸的对映选择性合成。

  摘要：

  (2S)-2-苄氧基甲基-3-(2-氟-4-甲氧基苯基)-丙酸、(2S)-2-苄氧基甲基-3-(2-氟-4-甲基苯基)丙酸和(2S)的合成)-2-苄基-氧甲基-3-(2,4-二甲基苯基)丙酸通过TiCl4介导的相应(4R)-4-苄基-3-[3-(2-氟-4-甲氧基苯基)烷基化-, 2-氟-4-甲基苯基-, 2,4-二甲基苯基-)丙酰基]-2-恶唑烷酮，然后水解手性助剂。烷基化反应的立体化学由 (4R)-4-benzyl-3-[(2S)-2-benzyloxymethyl-3-(2-fluoro-4-methylphenyl)propionyl]-2 的 X 射线晶体结构证实-恶唑烷酮。

  DOI：

  10.3390/90600449
• 作为产物：
  描述：

  三甲基膦酰基乙酸酯 、 2-氟-4-甲氧基苯甲醛 在 sodium methylate 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 3-(2-氟-4-甲氧基苯基)丙烯酸甲酯
  参考文献：
  名称：

  Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections

  摘要：

  Inhibition of S. aureus diapophytoene desaturase (CrtN) could serve as an alternative approach for addressing the tricky antibiotic resistance by blocking the biosynthesis of carotenoid pigment which shields the bacterium from host oxidant killing. In this study, we designed and synthesized 44 derivatives with piperonyl scaffold targeting CrtN and the structure-activity relationships (SARs) were examined extensively to bring out the discovery of 21b with potent efficacy and better hERG safety profile compared to the first class CrtN inhibitor benzocycloalkane derivative 2. Except the excellent pigment inhibitory activity against wild-type S. aureus, 21b also showed excellent pigment inhibition against four pigmented MRSA strains. In addition, H2O2 killing and human whole blood killing assays proved 21b could sensitize S. aureus to be killed under oxidative stress conditions. Notably, the murine study in vivo validated the efficacy of 21b against pigmented S. aureus Newman, vancomycin-intermediate S. aureus Mu50 and linezolid-resistant S. aureus NRS271. (C) 2018 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2017.12.090

文献信息

• [EN] NEW INDANYLOXYPHENYLCYCLOPROPANECARB OXYLIC ACIDS<br/>[FR] NOUVEAUX ACIDES INDANYLOXYPHÉNYLCYCLOPROPANECARBOXYLIQUES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2013178575A1

  公开（公告）日：2013-12-05

  The present invention relates to compounds of general formula I, (I) wherein the groups R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

  本发明涉及一般式I（I）的化合物，其中基团R1、R2、R3、m和n的定义如权利要求1所述，具有有价值的药理特性，特别是结合GPR40受体并调节其活性。这些化合物适用于治疗和预防受该受体影响的疾病，如代谢性疾病，特别是2型糖尿病。此外，本发明涉及用于合成一般式I化合物的新中间体。
• 6-MEMBERED CYCLIC AMINES OR LACTAMES SUBSTITUTED WITH UREA AND PHENYL
  申请人：GRÜNENTHAL GMBH

  公开号：US20180078541A1

  公开（公告）日：2018-03-22

  The present invention relates to a compound according to general formula (I) which acts as a modulator of FPR2 and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by FPR2.

  本发明涉及一种符合通用式（I）的化合物，该化合物作为FPR2的调节剂，并可用于治疗和/或预防至少部分由FPR2介导的疾病。
• 6-membered cyclic amines or lactames substituted with urea and phenyl
  申请人：GRÜNENTHAL GMBH

  公开号：US10265310B2

  公开（公告）日：2019-04-23

  The present invention relates to a compound according to general formula (I) which acts as a modulator of FPR2 and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by FPR2.

  本发明涉及一种符合通式 (I) 的化合物 它作为 FPR2 的调节剂，可用于治疗和/或预防至少部分由 FPR2 介导的疾病。
• Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators
  作者：Liangqin Guo、Zhixiong Ye、Feroze Ujjainwalla、Heather L. Sings、Iyassu K. Sebhat、John Huber、David H. Weinberg、Rui Tang、Tanya MacNeil、Constantin Tamvakopoulos、Qianping Peng、Euan MacIntyre、Lex H.T. van der Ploeg、Mark T. Goulet、Matthew J. Wyvratt、Ravi P. Nargund

  DOI：10.1016/j.bmcl.2008.04.049

  日期：2008.6

  Discovery of a series of tert-butyl pyrrolidine derived, potent and orally bioavailable melanocortin receptor subtype-4 (MC4R) selective modulators is disclosed. (C) 2008 Elsevier Ltd. All rights reserved.
• NEW INDANYLOXYPHENYLCYCLOPROPANECARB OXYLIC ACIDS
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP2855419B1

  公开（公告）日：2017-03-01